Download or read book Making Medicines Affordable written by National Academies of Sciences, Engineering, and Medicine and published by National Academies Press. This book was released on 2018-03-01 with total page 235 pages. Available in PDF, EPUB and Kindle. Book excerpt: Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Download or read book Drugs For Less written by Michael P. Cecil, M.D. and published by National Geographic Books. This book was released on 2005-04-19 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt: The first easy-to-use reference guide to saving 50% or more on the 250 most commonly prescribed medications in the United States. Over 40 million Americans lack health insurance. Another 40 million Americans are insured by Medicare and do not have prescription medications as a covered benefit. The 50 million covered by Medicaid are threatened by reduced benefits and limited formulary coverage. Even the 74 million Baby Boomers with health insurance are impacted, as pharmaceutical companies pass their costs on in the form of higher co-pays and insurance premiums. We all are affected by the problem of rising prescription drug costs. Drugs for Less is the answer to the problem. Empowering consumers with needed information, the book outlines seven simple strategies to reduce rising pharmaceutical prices. Here, for example, are tips on how to ensure that drugs you buy online are safe, guidelines on how to slice medications, and information on which generic drugs are more effective than the expensive brand-name versions. Most importantly, the book includes an extensive directory of the 250 most commonly prescribed medications with specific information on how to save money on that drug. Making sense of the convoluted system of pricing drugs and showing you how to beat it, Drugs for Less is the best investment you can make in your health. Visit www.drmichael.com for more information.
Download or read book Prescription Drugs for Half Price or Less written by Stephen Hyde and published by Bantam. This book was released on 2009-10-07 with total page 177 pages. Available in PDF, EPUB and Kindle. Book excerpt: If you want to save up to 50, 70, even 90% on your prescription drug costs, this is the book you need. Stephen S. S. Hyde, founder of Hyde Rx Services Corporation, is the leading authority on low-cost prescription drug benefits, and now he’s offering individual consumers the expertise he provides to America’s employers and health plans. With the simple, cost-saving techniques outlined in this revolutionary book, you can save literally hundreds, even thousands of dollars on your family’s prescription medications. You’ll discover: • The seven questions you should ask your doctor before he writes a prescription • How your pharmacist can save you money • How to get FREE prescription drugs • How to save on generic, over-the-counter, and brand-name drugs • How to get the lowest prices from retail, mail-order, online, and Canadian pharmacies • How you may be eligible for discount cards and other assistance programs • A Special Seniors Medicare Drug Benefit Report, and much more! With an appendix of directories, pharmacies, and websites to get you started, this book will pay for itself with your very first prescription!
Download or read book The Prescription Drug Savings Guide written by Phil Philcox and published by Citadel Press. This book was released on 2003 with total page 276 pages. Available in PDF, EPUB and Kindle. Book excerpt: This is an essential resource that enables the uninsured to save thousands ofdollars on medications.
Download or read book Medications for Opioid Use Disorder Save Lives written by National Academies of Sciences, Engineering, and Medicine and published by National Academies Press. This book was released on 2019-06-16 with total page 175 pages. Available in PDF, EPUB and Kindle. Book excerpt: The opioid crisis in the United States has come about because of excessive use of these drugs for both legal and illicit purposes and unprecedented levels of consequent opioid use disorder (OUD). More than 2 million people in the United States are estimated to have OUD, which is caused by prolonged use of prescription opioids, heroin, or other illicit opioids. OUD is a life-threatening condition associated with a 20-fold greater risk of early death due to overdose, infectious diseases, trauma, and suicide. Mortality related to OUD continues to escalate as this public health crisis gathers momentum across the country, with opioid overdoses killing more than 47,000 people in 2017 in the United States. Efforts to date have made no real headway in stemming this crisis, in large part because tools that already existâ€"like evidence-based medicationsâ€"are not being deployed to maximum impact. To support the dissemination of accurate patient-focused information about treatments for addiction, and to help provide scientific solutions to the current opioid crisis, this report studies the evidence base on medication assisted treatment (MAT) for OUD. It examines available evidence on the range of parameters and circumstances in which MAT can be effectively delivered and identifies additional research needed.
Download or read book Pain Management and the Opioid Epidemic written by National Academies of Sciences, Engineering, and Medicine and published by National Academies Press. This book was released on 2017-09-28 with total page 483 pages. Available in PDF, EPUB and Kindle. Book excerpt: Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Download or read book Prescription Drugs for Half Price Or Less written by Stephen Hyde Hyde and published by . This book was released on 2009 with total page pages. Available in PDF, EPUB and Kindle. Book excerpt: If you want to save up to 50, 70, even 90% on your prescription drug costs, this is the book you need. Stephen S. S. Hyde, founder of Hyde Rx Services Corporation, is the leading authority on low-cost prescription drug benefits, and now he's offering individual consumers the expertise he provides to America's employers and health plans. With the simple, cost-saving techniques outlined in this revolutionary book, you can save literally hundreds, even thousands of dollars on your family's prescription medications. You'll discover:- The seven questions you should ask your doctor before he writes a prescription - How your pharmacist can save you money - How to get FREE prescription drugs - How to save on generic, over-the-counter, and brand-name drugs - How to get the lowest prices from retail, mail-order, online, and Canadian pharmacies - How you may be eligible for discount cards and other assistance programs - A Special Seniors Medicare Drug Benefit Report, and much more!With an appendix of directories, pharmacies, and websites to get you started, this book will pay for itself with your very first prescription!From the Trade Paperback edition.
Download or read book Countering the Problem of Falsified and Substandard Drugs written by Institute of Medicine and published by National Academies Press. This book was released on 2013-06-20 with total page 377 pages. Available in PDF, EPUB and Kindle. Book excerpt: The adulteration and fraudulent manufacture of medicines is an old problem, vastly aggravated by modern manufacturing and trade. In the last decade, impotent antimicrobial drugs have compromised the treatment of many deadly diseases in poor countries. More recently, negligent production at a Massachusetts compounding pharmacy sickened hundreds of Americans. While the national drugs regulatory authority (hereafter, the regulatory authority) is responsible for the safety of a country's drug supply, no single country can entirely guarantee this today. The once common use of the term counterfeit to describe any drug that is not what it claims to be is at the heart of the argument. In a narrow, legal sense a counterfeit drug is one that infringes on a registered trademark. The lay meaning is much broader, including any drug made with intentional deceit. Some generic drug companies and civil society groups object to calling bad medicines counterfeit, seeing it as the deliberate conflation of public health and intellectual property concerns. Countering the Problem of Falsified and Substandard Drugs accepts the narrow meaning of counterfeit, and, because the nuances of trademark infringement must be dealt with by courts, case by case, the report does not discuss the problem of counterfeit medicines.
Download or read book Pharmaceutical Calculations written by Mitchell J. Stoklosa and published by . This book was released on 1986 with total page 428 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Generic written by Jeremy A. Greene and published by JHU Press. This book was released on 2014-10-27 with total page 375 pages. Available in PDF, EPUB and Kindle. Book excerpt: The turbulent history of generic pharmaceuticals raises powerful questions about similarity and difference in modern medicine. Generic drugs are now familiar objects in clinics, drugstores, and households around the world. We like to think of these tablets, capsules, patches, and ointments as interchangeable with their brand-name counterparts: why pay more for the same? And yet they are not quite the same. They differ in price, in place of origin, in color, shape, and size, in the dyes, binders, fillers, and coatings used, and in a host of other ways. Claims of generic equivalence, as physician-historian Jeremy Greene reveals in this gripping narrative, are never based on being identical to the original drug in all respects, but in being the same in all ways that matter. How do we know what parts of a pill really matter? Decisions about which differences are significant and which are trivial in the world of therapeutics are not resolved by simple chemical or biological assays alone. As Greene reveals in this fascinating account, questions of therapeutic similarity and difference are also always questions of pharmacology and physiology, of economics and politics, of morality and belief. Generic is the first book to chronicle the social, political, and cultural history of generic drugs in America. It narrates the evolution of the generic drug industry from a set of mid-twentieth-century "schlock houses" and "counterfeiters" into an agile and surprisingly powerful set of multinational corporations in the early twenty-first century. The substitution of bioequivalent generic drugs for more expensive brand-name products is a rare success story in a field of failed attempts to deliver equivalent value in health care for a lower price. Greene’s history sheds light on the controversies shadowing the success of generics: problems with the generalizability of medical knowledge, the fragile role of science in public policy, and the increasing role of industry, marketing, and consumer logics in late-twentieth-century and early twenty-first century health care.
Download or read book Bottle of Lies written by Katherine Eban and published by HarperCollins. This book was released on 2020-06-23 with total page 512 pages. Available in PDF, EPUB and Kindle. Book excerpt: A NEW YORK TIMES BESTSELLER New York Times 100 Notable Books of 2019 New York Public Library Best Books of 2019 Kirkus Reviews Best Health and Science Books of 2019 Science Friday Best Books of 2019 New postscript by the author From an award-winning journalist, an explosive narrative investigation of the generic drug boom that reveals fraud and life-threatening dangers on a global scale—The Jungle for pharmaceuticals Many have hailed the widespread use of generic drugs as one of the most important public-health developments of the twenty-first century. Today, almost 90 percent of our pharmaceutical market is comprised of generics, the majority of which are manufactured overseas. We have been reassured by our doctors, our pharmacists and our regulators that generic drugs are identical to their brand-name counterparts, just less expensive. But is this really true? Katherine Eban’s Bottle of Lies exposes the deceit behind generic-drug manufacturing—and the attendant risks for global health. Drawing on exclusive accounts from whistleblowers and regulators, as well as thousands of pages of confidential FDA documents, Eban reveals an industry where fraud is rampant, companies routinely falsify data, and executives circumvent almost every principle of safe manufacturing to minimize cost and maximize profit, confident in their ability to fool inspectors. Meanwhile, patients unwittingly consume medicine with unpredictable and dangerous effects. The story of generic drugs is truly global. It connects middle America to China, India, sub-Saharan Africa and Brazil, and represents the ultimate litmus test of globalization: what are the risks of moving drug manufacturing offshore, and are they worth the savings? A decade-long investigation with international sweep, high-stakes brinkmanship and big money at its core, Bottle of Lies reveals how the world’s greatest public-health innovation has become one of its most astonishing swindles.
Download or read book CDC Yellow Book 2018 Health Information for International Travel written by Centers for Disease Control and Prevention CDC and published by Oxford University Press. This book was released on 2017-04-17 with total page 705 pages. Available in PDF, EPUB and Kindle. Book excerpt: THE ESSENTIAL WORK IN TRAVEL MEDICINE -- NOW COMPLETELY UPDATED FOR 2018 As unprecedented numbers of travelers cross international borders each day, the need for up-to-date, practical information about the health challenges posed by travel has never been greater. For both international travelers and the health professionals who care for them, the CDC Yellow Book 2018: Health Information for International Travel is the definitive guide to staying safe and healthy anywhere in the world. The fully revised and updated 2018 edition codifies the U.S. government's most current health guidelines and information for international travelers, including pretravel vaccine recommendations, destination-specific health advice, and easy-to-reference maps, tables, and charts. The 2018 Yellow Book also addresses the needs of specific types of travelers, with dedicated sections on: · Precautions for pregnant travelers, immunocompromised travelers, and travelers with disabilities · Special considerations for newly arrived adoptees, immigrants, and refugees · Practical tips for last-minute or resource-limited travelers · Advice for air crews, humanitarian workers, missionaries, and others who provide care and support overseas Authored by a team of the world's most esteemed travel medicine experts, the Yellow Book is an essential resource for travelers -- and the clinicians overseeing their care -- at home and abroad.
Download or read book Pharmaceutical R D written by and published by DIANE Publishing. This book was released on 1993 with total page 380 pages. Available in PDF, EPUB and Kindle. Book excerpt: Analyzes the costs, risks, and economic rewards of pharmaceutical R&D and the impact of public policy on both costs and returns. Examines the rapid increase in pharmaceutical R&D that began in the 1980s in the light of trends in science, technology, drug discovery, and health insurance coverage; Government regulation; product liability; market competition; Federal tax policy; and Federal support of prescription drug research. 12 appendices, including a glossary of terms.
Download or read book A Life Less Anxious written by Steve Pavilanis and published by Alpen Publishing Company. This book was released on 2009-11-11 with total page 182 pages. Available in PDF, EPUB and Kindle. Book excerpt: Do you have a tremendous fear of public speaking, flying, or other social situations? Do you live in fear of having another panic attack? Do you depend on antidepressants, alcohol, or other medications to calm you down or help you sleep? If so, you're not alone. Tens of millions of Americans are affected by anxiety disorders and many more worldwide. I personally struggled for five years with extreme social anxiety and panic attacks, constantly battling my own scary and seemingly uncontrollable thoughts. I finally found the path to freedom from excessive worry, medication, and fear. I have overcome these problems and now live my life with a greater sense of inner peace and calmness. I'm not a medical doctor, psychiatrist, or therapist of any sort. I am simply a normal guy whose life was once overrun with constant worry, fear, and depression. With great determination, research, and trial and error, I have returned to a healthy state of wholeness and optimism. My book details many of the problems I encountered daily, struggles that anyone suffering from anxiety can certainly relate to. I expand in detail upon my journey towards personal freedom, the valuable lessons I learned along the way, and how to apply them to your own life. I discuss why I had several severe relapses with my progress, and how you can avoid the same pitfalls. Some of the highlights of the book include: Education - Explanations of what anxiety is, and how it affects your body and mind. Strategy - How to formulate a plan to overcome your own fears and self-created limitations. Techniques - Discussions of the various physical and mental techniques I found most helpful in my recovery and still practice today, including meditation. Inspiration - I show you how to gain a sense of urgency and inspiration to change your life. Life Changes - Adjustments to your lifestyle to help encourage a peaceful mind and body. Are you ready to get your life back?
Download or read book Greater Access to Generic Drugs written by Michelle Meadows and published by . This book was released on 2003 with total page 8 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Top 200 Drugs written by Professor Lohner Mba Bs Pharm and published by . This book was released on 2020-04-27 with total page 42 pages. Available in PDF, EPUB and Kindle. Book excerpt: Many medical, nursing, and pharmacy students think that it is really difficult to remember all the drugs so they say, just memorize whatever you can. There is a way or a "hack" to remember all the 200 drugs. You can do this by grouping them basedon their use, the organs or systems they affect, knowing the most commonly used prefixes, roots, and suffixes used in generic names of drugs. What do I mean by that?Here's an example: -al, a common suffix for drugs like tadalafil (Brand Name: Cialis) and sildenal (Brand Name: Viagra). These drugs fall under the category PDE inhibitor or phosphodiesterase inhibitor. These are drugs that are used for erectiledysfunction or ED. Another example is -sone, a suffix for a drug called fluticasone. Fluticasone is a corticosteroid. Corticosteroids are anti-inflammatory drugs so, it is safe to make the educated guess during a test that drugs that end in -sone (applies to generic names only) are steroids. Barbiturates, group of drugs used as anesthetics or antiepileptics, have the root -barb. Examples of these drugs are: phenobarbital and secobarbital. The suffix -olol is used for beta blockers. Beta blockers are drugs used for hypertension. Another one would be -statin, atorvastatin and simvastatin are used to lower elevated cholesterol levels and these drugs are classified as antihyperlipidemics or HMG Co-enzyme A Reductase Inhibitor. Statins are used to lower elevated cholesterol levels in the blood.Yes, studying DRUGS can be gruesome. Students, more often than not, get overwhelmed by so much information given to them to study all at once. A lot of them give up due to information overload or anxiety that comes with seeing all the thick textbooks and materials that need to be covered, studied, understood and tested on. This is why I organized not just the Top 200 Drugs but, the Top 250 Drugs in this book for you by their class and I included the cheat codes in memorizing them easily.Students also told me that the list was no good since "the list doesn't talk to them" like I do during lectures and they do not know how to pronounce half the drugs on the list. Oh yeah, I hear you say that, too, "Yeah, it's a nice and handy list but, I do not know how to say or pronounce more than half of these drugs, if not all." You do not have to worry, I have made a compilation of my audio lectures from my live classes to go with this ebook so, MEMORIZING DRUGS CAN REALLY BE THIS RIDICULOUSLY EASY and the link is inside the book.Repetition is key to remembering anything. And by you carrying me, I mean, carrying this ebook with you everywhere you go, you can pull it out anytime, anywhere, for a quick study or review. I will be with you everywhere you go, I promise and because I really want you to succeed, I included a list of the Top 250 Drugs, instead of just the Top 200 Drugs. -Prof. Lohner
Download or read book Therapeutic Drug Monitoring written by Amitava Dasgupta and published by Academic Press. This book was released on 2012-06-07 with total page 469 pages. Available in PDF, EPUB and Kindle. Book excerpt: Therapeutic Drug Monitoring: Newer Drugs and Biomarkers features timely topics such as the monitoring of classical and newer drugs, pharmacogenomics and the application of biomarkers in therapeutic drug monitoring. This reference also discusses the limitations of current commercially available immunoassays for therapeutic monitoring. It presents new and sophisticated techniques used for proper determination of blood levels and the clinical utility of therapeutic drug monitoring of contemporary drugs. Written by leading international experts and geared toward clinical pathologists, toxicologists, clinical chemists, laboratory professionals and physicians, this book is an essential resource on the current practice of therapeutic drug monitoring in improving patient safety. - Includes both the technical and clinical issues associated with therapeutic drug monitoring - Discusses the utility of therapeutic drug monitoring of newer drugs such as antiretroviral agents, anticonvulsants, antidepressants etc. - Provides up-to-date information on issues in pharmacogenomics and personalized medicine with emphasis on therapy with warfarin, certain anticancer drugs and antidepressants - Covers important content on the limitations of commercially available immunoassays (chemical tests) for therapeutic drug monitoring and additional analytical techniques
